Total Voting Rights

Summary by AI BETAClose X

RHI Magnesita N.V. has announced its total voting rights as of 28 February 2026, stating that its issued share capital comprises 47,307,527 ordinary shares, with an additional 2,170,178 ordinary shares held in treasury. Consequently, the aggregate voting rights available to shareholders, excluding treasury shares, stand at 47,307,527. This figure will serve as the denominator for shareholders and other obligated parties when calculating whether they need to notify any changes to their interests in the company under the FCA's Disclosure Guidance and Transparency Rules.

Disclaimer*

RHI Magnesita N.V.
02 March 2026
 

RHI Magnesita N.V.

 

("RHI Magnesita" the "Company" or the "Group")

 

Total Voting Rights

 

In accordance with DTR 5.6 of the FCA's Disclosure Guidance and Transparency Rules and Article 15 of the EU's Transparency Directive, RHI Magnesita announces that, as at 28 February 2026, its issued share capital consisted of 47,307,527 ordinary shares and 2,170,178 ordinary shares held in treasury.

 

Excluding the 2,170,178 ordinary shares held in treasury, RHI Magnesita has shares in issue with aggregate voting rights of 47,307,527.

 

The above figure (47,307,527) may be used by shareholders (and others with notification obligations) as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, RHI Magnesita under the FCA's Disclosure Guidance and Transparency Rules.  

 

For further enquiries please contact:

Alexander Ordosch, Head of Investor Relations             

Tel: +43 699 1870 6162

Email: alexander.ordosch@rhimagnesita.com

                                                                                                                                                               

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings